The role of turmerones on curcumin transportation and P-glycoprotein activities in intestinal caco-2 cells

Journal of Medicinal Food

Volumn 15, Issue 3, 2012, Pages 242-252

  Yue, Grace G L ^a   Cheng, Sau Wan ^a   Yu, Hua ^a   Xu, Zi Sheng ^a   Lee, Julia K M ^a   Hon, Po Ming ^a   Lee, Mavis Y H ^a   Kennelly, Edward J ^b   Deng, Gary ^c   Yeung, Simon K ^c   Cassileth, Barrie R ^c   Fung, Kwok Pui ^a   Leung, Ping Chung ^a   Lau, Clara B S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Caco 2 cells9; Curcuma longa; Curcumin; P glycoprotein; Turmerone

Indexed keywords

ALPHA TURMERONE; CURCUMA LONGA EXTRACT; CURCUMIN; DIGOXIN; GLYCOPROTEIN P; MESSENGER RNA; RHODAMINE 123; TURMERONE; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; CELL STRAIN CACO 2; DRUG ABSORPTION; DRUG MECHANISM; INTESTINE CELL; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ATP-BINDING CASSETTE TRANSPORTERS; CACO-2 CELLS; CELL SURVIVAL; COLONIC NEOPLASMS; CURCUMA; CURCUMIN; ENTEROCYTES; GASTROINTESTINAL AGENTS; GENE EXPRESSION REGULATION; HUMANS; INTESTINAL ABSORPTION; KETONES; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; PHYTOTHERAPY; PLANT EXTRACTS; RNA, MESSENGER; SESQUITERPENES; SOLUBILITY;

ANIMALIA; CURCUMA LONGA;

EID: 84863262829     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2011.1845     Document Type: Article

References (43)

1. Ministry of Health & Family Welfare, Government of India: The Ayurvedic Pharmacopoeia of India, Part I, Vol. I. The Controller of Publications Civil Lines, New Delhi, 2001, pp. 45-46.
2. Chinese Pharmacopoeia Commission: Chinese Pharmacopoeia, Vol. I. China Medical Science and Technology Press, Beijing, 2010, pp. 247-248.
3. Chauhan DP: Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des 2002;8:1695-1706. (Pubitemid 34846196)
4. Mohandas KM, Desai DC: Epidemiology of digestive tract cancers in India. V. Large and small bowel. Indian J Gastroenterol 1999;18:118-121.
5. Sinha R, Anderson DE, McDonald SS, Greenwald P: Cancer risk and diet in India. J Postgrad Med 2003;49:222-228. (Pubitemid 37493414)
6. Gopalan B, Goto M, Kodama A, Hirose T: Supercritical carbon dioxide extraction of turmeric (Curcuma longa). J Agric Food Chem 2000;48:2189-2192. (Pubitemid 30431210)
7. Braga MEM, Leal PF, Carvalho JE, Meireles MAA: Comparison of yield, composition and antioxidant activity of turmeric (Curcuma longa L.) extracts obtained using various techniques. J Agric Food Chem 2003;51:6604-6611.
8. Shi XY, Ku K, Tan R: Mechanistic study of anti-tumor effect of turmeric volatile oil. Pharmacol Clin Chin Mater Med 2003;19: 15-16.
9. Jayaprakasha GK, Jena BS, Negi PS, Sakariah KK: Evaluation of antioxidant activities and antimutagenicity of turmeric oil: a byproduct from curcumin production. Z Naturforsch C 2002;57: 828-835. (Pubitemid 35280746)
10. Ji M, Choi J, Lee J, Lee Y: Induction of apoptosis by ar-turmerone on various cell lines. Int J Mol Med 2004;14:253-256.
11. Goel A, Kunnumakkara AB, Aggarwal BB: Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 2008;75: 787-809.
12. Plummer SM, Holloway KA, Manson MM, et al.: Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappa B activation via the NIK/IKK signalling complex. Oncogene 1999;18: 6013-6020. (Pubitemid 29535013)
13. Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB: Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaB alpha kinase and Akt activation. Mol Pharmacol 2006;69:195-206. (Pubitemid 43048906)
14. Anuchapreeda S, Tima S, Duangrat C, Limtrakul P: Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines. Cancer Chemother Pharmacol 2008;62:585-594.
15. Cao J, Liu Y, Jia L, et al.: Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells. Free Radic Biol Med 2007;43:968-975. (Pubitemid 47223632)
16. Yue GG, Chan BC, Hon PM, et al.: Evaluation of in vitro antiproliferative and immunomodulatory activities of compounds isolated from Curcuma longa. Food Chem Toxicol 2010;48: 2011-2020.
17. Wahlstrom B, Blennow G: A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh) 1978;43:86-92. (Pubitemid 9016316)
18. Ravindranath V, Chandrasekhara N: Absorption and tissue distribution of curcumin in rats. Toxicology 1980;16:259-265. (Pubitemid 10056763)
19. Holder GM, Plummer JL, Ryan AJ: The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica 1978;8:761-768. (Pubitemid 9119050)
20. Yang KY, Lin LC, Tseng TY, Wang SC, Tsai TH: Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2007;853:183-189.
21. Cheng AL, Hsu CH, Lin JK, et al.: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001;21:2895-2900.
22. Sharma RA, McLelland HR, Hill KA, et al.: Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 2001;7:1894-1900. (Pubitemid 32994823)
23. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS: Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998;64:353-356. (Pubitemid 28234275)
24. Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP, Gescher AJ: Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol 2007;60:171-177. (Pubitemid 46742531)
25. Bisht S, Feldmann G, Soni S, et al.: Polymeric nanoparticleencapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnol 2007;5:3.
26. Sun A, Shoji M, Lu YJ, Liotta DC, Snyder JP: Synthesis of EF24-tripeptide chloromethyl ketone: a novel curcumin-related anticancer drug delivery system. J Med Chem 2006;49:3153-3158. (Pubitemid 43830514)
27. Tomren MA, Másson M, Loftsson T, Tønnesen HH: Studies on curcumin and curcuminoids XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin. Int J Pharm 2007;338:27-34. (Pubitemid 46777212)
28. Artursson P, Karlsson J: Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 1991;175:880-885.
29. Zhang W, Lim LY: Effects of spice constituents on Pglycoprotein-mediated transport and CYP3A4-mediated metabolism in vitro. Drug Metab Dispos 2008;36:1283-1290. (Pubitemid 351929312)
30. Hou XL, Takahashi K, Tanaka K, et al.: Curcuma drugs and curcumin regulate the expression and function of P-gp in Caco-2 cells in completely opposite ways. Int J Pharm 2008;358:224-229.
31. Hou XL, Takahashi K, Kinoshita N, et al.: Possible inhibitory mechanism of Curcuma drugs on CYP3A4 in 1alpha,25 dihydroxyvitamin D3 treated Caco-2 cells. Int J Pharm 2007;337: 169-177. (Pubitemid 46756042)
32. Ampasavate C, Sotanaphun U, Phattanawasin P, Piyapolrungroj N: Effects of Curcuma spp. on P-glycoprotein function. Phytomedicine 2010;17:506-512.
33. Graber-Maier A, Berger BK, Aeschlimann J, et al.: Effects of Curcuma extracts and curcuminoids on expression of Pglycoprotein and cytochrome P450 3A4 in the intestinal cell culture model LS180. Planta Med 2010;76:1866-1870.
34. Morris ME, Zhang S: Flavonoid-drug interactions: effects of flavonoids on ABC transporters. Life Sci 2006;78:2116-2130.
35. Brand W, van der Wel PA, Rein MJ, et al.: Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers. Drug Metab Dispos 2008;36:1794-1802.
36. Usta M, Wortelboer HM, Vervoort J, et al.: Human glutathione S-transferase-mediated glutathione conjugation of curcumin and efflux of these conjugates in Caco-2 cells. Chem Res Toxicol 2007;20:1895-1902.
37. Kurien BT, Singh A, Matsumoto H, Scofield RH: Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev Technol 2007;5:567-576. (Pubitemid 47548073)
38. Yadav VR, Prasad S, Kannappan R, et al.: Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochem Pharmacol 2010;80:1021-1032.
39. Dressman JB, Vertzoni M, Goumas K, Reppas C: Estimating drug solubility in the gastrointestinal tract. Adv Drug Deliv Rev 2007;59:591-602. (Pubitemid 47287780)
40. Kurien BT, Scofield RH: Curcumin/turmeric solubilized in sodium hydroxide inhibits HNE protein modification-an in vitro study. J Ethnopharmacol 2007;110:368-373. (Pubitemid 46283670)
41. Kawamori T, Lubet R, Steele VE, et al.: Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 1999;59:597-601. (Pubitemid 29076056)
42. Garcea G, Berry DP, Jones DJ, et al.: Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev 2005;14:120-125. (Pubitemid 40165291)
43. Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S: A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced preparation of curcumin. Indian J Pharm Sci 2008;70:445-449.